Prescribed by Hong Kong-registered Western medical doctors, we offer GLP-1 weight-loss pens and oral fat-blocking pills. Clinically proven to help you lose up to 22.5% of your body weight, our service is safe and confidential, with medication delivered to your door in as little as 4 hours.










GLP-1 agonists have been approved by the FDA and EMA for weight management, and their safety and efficacy have been demonstrated in large-scale clinical trials. Common side effects primarily include gastrointestinal reactions (such as nausea and diarrhea), which typically occur early in treatment and subside over time.
Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist administered via weekly injection; clinical studies have shown it can lead to weight loss of up to 22.5%. Its dual mechanism of action allows for more comprehensive regulation of appetite and metabolism, potentially resulting in more significant weight loss.
Wegovy (semaglutide) is a GLP-1 single receptor agonist administered once weekly, which can lead to weight loss of up to 15%. As one of the most widely used weight-loss injections globally, its safety and efficacy have been validated by over 20 million people, resulting in the most extensive real-world data and long-term usage experience.
Both products are administered via weekly injection and deliver excellent results, making them suitable for people with different needs: For those seeking the highest weight-loss potential, Mounjaro’s dual mechanism may be more appealing; for those who prefer the most widely used option with the most data to support it, Wegovy is the better choice. Ultimately, to determine which one is right for you, we recommend consulting your doctor to decide based on your individual constitution and goals.
We recommend using this product for at least 3–6 months to assess its effectiveness. Long-term use can help maintain weight loss results; after discontinuing use, you should combine the product with a healthy diet and exercise to prevent weight regain.
Injectable medications (GLP-1) reduce appetite by mimicking gut hormones and produce more significant weight loss (15–22.5%). Oral fat-blocking pills promote weight loss by inhibiting fat absorption; their effects are relatively mild (5–10%), but they are more convenient to use.
GLP-1 agonists naturally reduce appetite, so strict dieting is not necessary. However, combining them with a balanced diet and moderate exercise is recommended for optimal results. For fat-blocking pills, it is recommended to follow a low-fat diet to minimize gastrointestinal side effects.
Common side effects of GLP-1 agonists include nausea, diarrhea, and constipation, which typically occur early in treatment and gradually subside. Oil-absorbing tablets may cause oily stools. If you experience severe discomfort, contact your doctor immediately.